Keywords: troubled, outlook, future, reports, alizyme, uk, biopharmaceutical

Troubled outlook for future, reports Alizyme

Article | 29 May 2009

Print This

UK biopharmaceutical drug developer Alizyme has expressed a "material uncertainty over its ability to continue as a going concern." The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in